...
首页> 外文期刊>European Heart Journal - Case Reports >Mechanical circulatory support for refractory cardiogenic shock in Takotsubo syndrome: a case report and review of the literature
【24h】

Mechanical circulatory support for refractory cardiogenic shock in Takotsubo syndrome: a case report and review of the literature

机译:Takotsubo综合征难治性心源性休克的机械循环支持:一例病例并文献复习

获取原文

摘要

Takotsubo syndrome (TTS) complicated by refractory cardiogenic shock is a challenging clinical problem, as treatment with inotropic agents and/or vasopressors is contraindicated. We illustrate this by a patient presenting with chest pain and shortness of breath caused by TTS complicated by cardiogenic shock requiring mechanical circulatory support (MCS). The patient received central extracorporeal life support with a cannula in the left atrium (pre-load reduction of left ventricle) and the return cannula in the ascending aorta (neutral on afterload). Treatment with MCS was complicated by a cardiac tamponade. Left ventricular function recovered after 24?h, and the patient was doing well at the outpatient clinic 7?weeks after discharge. In addition, we reviewed the literature (PubMed search) reporting on MCS in patients with TTS. Including our patient, 17 cases of TTS induced cardiogenic shock receiving MCS have been reported. Age of the patients ranged from 16?years to 74?years, and 71% of the patients were female. Extracorporeal life support was the most used type of MCS (82% of the cases). Two patients died, and complications of MCS were rare (one case of leg ischaemia). Theoretically, MCS devices that reduce pre-load and are neutral on afterload are preferable. However, no specific type of MCS can be recommended as randomized trials are lacking. In conclusion, our case and the available literature suggests that MCS in TTS induced refractory cardiogenic shock is an immediate and feasible lifesaving treatment.
机译:Takotsubo综合征(TTS)并伴有难治性心源性休克,这是一个具有挑战性的临床问题,因为禁忌使用正性肌力药和/或升压药治疗。我们通过出现由TTS并发需要机械循环支持(MCS)的心源性休克引起的胸痛和呼吸急促的患者来说明这一点。患者接受中央体外生命支持,左心房使用插管(减少左心室的负荷),升主动脉返回插管(后负荷为中性)。 MCS的治疗因心脏压塞而变得复杂。 24小时后,左心室功能恢复,出院后7周,患者在门诊就诊情况良好。此外,我们回顾了有关TTS患者MCS的文献报道(PubMed搜索)。包括我们的患者在内,已有17例TTS诱发的心源性休克接受MCS报道。患者年龄在16岁至74岁之间,其中71%为女性。体外生命支持是最常用的MCS类型(占案例的82%)。 2例患者死亡,MCS并发症很少(1例腿部缺血)。从理论上讲,MCS装置最好减少预载,并在后载时保持中性。但是,由于缺乏随机试验,因此不建议使用特定类型的MCS。总之,我们的病例和现有文献表明,MCS在TTS诱导的难治性心源性休克中是一种即时可行的挽救生命的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号